The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-4-chloro-7-(4-(trifluoromethyl)benzyl)-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one ID: ALA4874124
PubChem CID: 162767101
Max Phase: Preclinical
Molecular Formula: C14H10ClF3N4O
Molecular Weight: 342.71
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(Cl)c2c(n1)N(Cc1ccc(C(F)(F)F)cc1)C(=O)C2
Standard InChI: InChI=1S/C14H10ClF3N4O/c15-11-9-5-10(23)22(12(9)21-13(19)20-11)6-7-1-3-8(4-2-7)14(16,17)18/h1-4H,5-6H2,(H2,19,20,21)
Standard InChI Key: RFNSMFOUHVZBMK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
7.9325 -25.7168 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.7220 -26.5092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5136 -26.2953 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.0663 -24.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0652 -24.8235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7732 -25.2324 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7714 -23.5951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4801 -24.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4849 -24.8235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2693 -25.0733 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7493 -24.4045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2614 -23.7414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3571 -25.2315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7690 -22.7779 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.5263 -25.8490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3266 -26.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5789 -26.7923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6617 -25.5680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8628 -25.4063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9226 -26.3469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3787 -26.9552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5664 -24.3996 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9803 -27.2874 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 8 1 0
5 13 1 0
7 14 1 0
10 15 1 0
15 16 1 0
16 17 2 0
17 21 1 0
20 18 1 0
18 19 2 0
19 16 1 0
20 21 2 0
11 22 2 0
20 2 1 0
2 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.71Molecular Weight (Monoisotopic): 342.0495AlogP: 2.82#Rotatable Bonds: 2Polar Surface Area: 72.11Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.06CX Basic pKa: 1.88CX LogP: 2.88CX LogD: 2.88Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.85Np Likeness Score: -1.22
References 1. Yang S, Yoon NG, Kim D, Park E, Kim SY, Lee JH, Lee C, Kang BH, Kang S.. (2021) Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity., 12 (7.0): [PMID:34267888 ] [10.1021/acsmedchemlett.1c00213 ]